transdermal ozone exposure linked to ~50% improvement in pain-free walking distance
Ozone therapy (intravenous infusions and aerosol baths) improved intermittent claudication distance on a track by approximately 50% and in a corridor by 34% in patients with obliterative atheromatosis.
What this means for you
Intermittent claudication is the leg pain and cramping that forces people to stop walking — caused by reduced blood flow to the muscles. In this finding, ozone exposure was associated with significantly longer distances before that pain set in. For anyone whose mobility is limited by circulation-related discomfort, improved walking tolerance can mean more independence and a more active daily life.
The published research
PMID: 12118202 Clinical Research
· 2001
This page describes a documented finding about the underlying wellness technology. It is not a marketing claim about any specific device. For information about HOCATT specifically, visit hocatt.com.